Zydus Wellness reported a 66.7% year-on-year increase in consolidated net sales to ₹14,299 million for the quarter ended June 30, 2026, driven by strong performance across its core nutrition and personal care brands. The company’s EBITDA grew 55.3% to ₹2,417 million, while profit after tax (PAT) declined 7.0% to ₹1,189 million due to acquisition-related amortization and interest costs. Despite the dip in PAT, adjusted net profit rose 26.5% to ₹1,679 million, reflecting robust underlying operational leverage.

The filing, submitted to BSE and NSE on August 4, 2026, details the unaudited financial results for Q1FY27. Revenue from operations stood at ₹14,370 million, up from ₹8,609 million in the corresponding period of the previous year. Gross contribution improved by 99.5% to ₹9,436 million, with gross margin expanding to 65.5% from 54.8%. The Board of Directors reviewed the performance, noting that international business delivered high double-digit growth despite geopolitical disruptions.

Financial Performance

The company’s financial metrics for Q1FY27 reflect significant top-line expansion, although net profitability was impacted by non-operating expenses related to recent acquisitions, specifically Comfort Click.

Profit after tax (PAT) declined 7.0% to ₹1,189 million due to interest expenses on Euro-denominated loans for the Comfort Click acquisition and amortization of acquired brands. However, adjusted net profit, which adds back amortization, rose 26.5% to ₹1,679 million. Adjusted EPS increased to ₹5.28 from ₹4.17.

Brand and Segment Highlights

Sugar Free strengthened its leadership in the sugar substitute category with a market share of 96.1%. Core brands Sugar Free D'Lite and I'm Lite delivered double-digit growth. Glucon-D maintained its leadership position with a 59.1% market share. RiteBite Max Protein continued to lead the nutrition protein bars, cookies, and chips category.

In personal care, Everyuth led the scrubs and peel-off categories with market shares of 49.4% and 75.5% respectively, improving its ranking to fourth in facial cleansing with an 8.2% share. Nycil maintained leadership in the prickly heat category with a 32.9% market share. Cuticolor performance was driven by strong consumer demand across organised retail channels.

Nutralite delivered double-digit growth, maintaining its leadership position in the fat spread category. Complan continued its growth momentum despite nutritional drink category degrowth, maintaining its fourth rank. The company launched Complan Power Play milk shake and VieMax Diabetes Care, a low glycaemic index nutrition solution.

Global Expansion

Under the Comfort Click portfolio, WeightWorld expanded its direct-to-consumer presence in the USA through entry into the Walmart Marketplace. In the UAE, WeightWorld and Maxmedix were launched on the Noon e-commerce platform. Domestically, domestic business grew 4.6% seasonally adjusted, while international revenues surged 24.8%. The Food and Nutrition segment led growth with a 34.5% year-on-year increase.

What the Numbers Show

The divergence between declining PAT and rising EBITDA highlights the impact of acquisition-related costs. While core operations generated stronger cash flows, non-operating expenses—specifically interest on foreign debt and brand amortization—compressed net profitability. This suggests that as amortization stabilizes and debt structures optimize, net margins could recover toward historical levels, assuming top-line momentum continues.

Zydus Wellness reported a consolidated net profit of ₹1,189 million for Q1FY26, down from ₹1,279 million in the same period last year. Despite a significant year-on-year rise in revenue from operations to ₹14,370 million from ₹8,609 million, the decline in net profit reflects increased operational costs and higher tax expenses. On the operating front, EBITDA rose sharply to ₹2.42 billion from ₹1.56 billion year-on-year, though the EBITDA margin contracted to 16.82% from 18.10% over the same period.

Q1FY26 Financial Performance

The Board of Directors approved the unaudited financial results on August 4, 2026, pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The results were reviewed by the Audit Committee and limited reviewed by Mukesh M. Shah & Co., the statutory auditors. The following table summarises the key consolidated financial metrics for the quarter:

Revenue from operations surged due to the inclusion of Comfort Click Limited (CCL), acquired in August 2025, and the consolidation of Naturell (India) Private Limited (NIPL) business effective September 20, 2025. However, total expenses rose sharply to ₹12,787 million from ₹7,186 million, driven by higher advertisement and promotion expenses (₹2,612 million vs ₹1,325 million) and other expenses (₹3,435 million vs ₹1,171 million). While absolute EBITDA expanded meaningfully on the back of higher revenues, the margin compression reflects the proportionally higher cost base introduced through these acquisitions.

Key Operational Developments

The company's segment remains "Consumer Products." The acquisition of CCL by subsidiary Alidac UK Limited for GBP 239 million plus a profit-ticker payment of GBP 2.64 million has significantly expanded the group's footprint. The results include CCL's operations from August 29, 2025, with provisional purchase price allocation figures. Additionally, the voluntary liquidation of NIPL was completed, with its business undertaking distributed to Zydus Wellness on a going concern basis.

Tax and Exceptional Items

Total tax expense increased to ₹432 million from ₹174 million in Q1FY25. This includes a reversal of Minimum Alternate Tax (MAT) credit entitlement of Nil for Q1FY26, compared to ₹146 million in Q1FY25. There were no exceptional items in Q1FY26, whereas FY25 saw exceptional expenses related to NIPL liquidation and CCL acquisition totalling ₹408 million.

Standalone Results

On a standalone basis, Zydus Wellness posted a net profit of ₹55 million for Q1FY26, up from ₹46 million in Q1FY25. Standalone revenue from operations was ₹1,530 million, compared to ₹1,409 million in the previous year. The standalone profit before tax was ₹74 million, slightly lower than ₹79 million in Q1FY25.